Testimonials

I manage horses that compete in a variety of disciplines and with the owner abilities ranging from novice to professional. As such, owner expectations vary markedly for managing the joint disease their horse may have. For example, cases of osteoarthritis typically seen can be early onset or be chronic in nature, and ranging from mild to severe. Patient age can be as young as 3 to over 20, and suffering from other disease processes such as endocrine issues. Managing client expectations is a challenge and an art. Finding the best solution for the client is the intended outcome and is not always easy to achieve.

Arthramid Vet enables me to effectively manage joints that have mild, moderate or severe osteoarthritic changes for a prolonged period of time and with very little chance of having an adverse reaction, even in those patients with other disease processes occurring concurrently. This provides peace of mind for the owner and myself. It also works out to be financially viable in the long-term. Arthramid has been a great option for horse owners of all levels to provide effective osteoarthritis management.

The longevity of effect and owner perception of arthramid not being a bioactive drug, are by far the biggest benefits. I would definitely recommend Arthramid Vet.

I was one of the first vets to use Arthramid worldwide and have now used Arthramid for over 10 years in our clinic. We have injected over a thousand horses and have found it to be very safe. It has been a major game-changer in the way we treat OA in our patients. We have fantastic results with really frustrating cases and are still working on new indications and treatment schemes for the product. We are also looking into the ongoing research, especially around the Mode of Action.

There are not many “new” products implemented in our OA Toolbox in recent years. Regenerative medicine and Bisphosphonates were the greatest new assets and I rate Arthramid Vet in the same league. 2.5% PAAG gives us the chance to minimize corticosteroids and we have no threats of “doping positive “ cases. As well, some horses, instead of being destroyed, are happily back in business. I would encourage every orthopaedic vet to try the product. They will love it, if their case selection is appropriate.

I have been using Arthramid Vet for more than 5 years treating thoroughbreds, standardbreds and equestrian horses. 90 % of my work is lameness identification and treatment. I have injected over 600 joints with Arthramid Vet and I have experienced no side affects.

I have used all the alternative joint treatments over the last 50 years and consider Arthramid with or without triamcinolone superior to all other treatments. 85 % of my thoroughbred lameness localises to the intercarpal joint. If we are treating early cases before severe bone changes have occurred we will achieve long term reduction of joint inflammation. I have been using it as prophylactic in some stables. If we have major bone changes I add triamcinolone as required. I have used Arthramid Vet in Fetlocks, TMT, Coffin, Pastern and stifle joints.In the gliding joints it is a superb product with spectacular results. In my experience joint pain on flexion is gone in 2 weeks and usually lameness markedly reduced but the maximum result is not achieved for 6 weeks. In summary Arthramid Vet is a very valuable treatment option and is my first port of call for all lamenesses involving non septic joint inflammation

I have been using Arthramid Vet for five years. I see lame horses that I qualify as “non-responders”. The diagnosis/localisation of pain is accurate on those cases, but they do not respond to rest, and corticosteroids +/- HA intrasynovial. These represent my biggest challenge. Arthramid Vet is often of great help on those cases in association with orthopaedic shoeing, magnetic diathermy and a revisited exercise program to regain and maintain soundness.

The second set of cases that represent a challenge are horses presented with poor performance. They are not genuinely lame, but several sites in their body including joints show signs of wear and tear. This accumulation of stress is associated with the athletic activity they perform and also to some individual predispositions to injury (poor conformation, overweight, lack of repair capacities). On these cases, Arthramid Vet for its long duration of action can help.

The third group of horses I see as a challenge are diagnosed with soft tissue injuries within synovial structures (tendon sheath, bursa or joint). In general, the body responds poorly to healing those lesions. It is still unclear to me if Arthramid Vet can help to return some of these horses to soundness when unsatisfactory healing of intrasynovial soft tissue has occurred.

Arthramid Vet is a very potent and very safe drug to use, and I recommend it to my clients and other vets. Arthramid Vet should be in the therapeutic toolbox of any equine veterinarian. I see Arthramid Vet as a solution with great potential, and more work is needed to refine its use.

Arthramid has proven to be highly effective in managing hock related lameness in horses, providing significant relief from joint pain and inflammation. This innovative treatment supports improved mobility and overall performance, making it an invaluable tool for maintaining the health of equine athletes.

“I like to use Arthramid in young horses since it’s synovitis, not DJD or OA, that is the most common cause of their lamenesses. When we target the synovial membrane it becomes more elastic and allows the synoviocytes to appropriately make HA. Arthramid helps meditate lameness and, I believe, prevent further joint breakdown in these patients.”

“I have used Arthramid® in cases of mild-moderate arthritis for several years. It has been effective in improving athletic performance in the majority of cases. The most impressive part has been the duration of efficacy of at least one year in almost every case.”

“I have been a big fan of Arthramid® for about 5 years. I use it extensively in joints with low-grade lameness issues caused by osteoarthritis and/or synovitis. In my opinion, it is efficacious, long-lasting and lower risk to cartilage than many alternatives.”

“By incorporating Arthramid® into my practice, I’m able to use far fewer steroids while still achieving excellent results, which gives me greater peace of mind for the long-term well-being of the horses under my care.”

“Arthramid® has become a cornerstone of my joint health treatment protocol.  In my experience, it consistently delivers superior results compared to traditional treatments. Whether used alone or in combination with steroids, Arthramid leads to improved joint health, enhanced overall performance, and longer-lasting results. It is my preferred choice for managing hock arthritis both in combination with steroid, but also as a standalone product. In addition, I find it particularly useful in managing arthritic metabolic horses where steroid is contraindicated and orthobiologics have not succeeded.”

“Arthramid is proving to be a mainstay in my practice. It has been particularly great for me in stifles, I love that it has long duration and no negative metabolic effects”

I have utilised hundreds of doses of 2.5% PAAG gel since 2014, and during this period I have learnt how to maximise its benefit in my caseload of predominantly Thoroughbred racehorses. In my opinion, it can minimise the use of intra-articular corticosteroids or other joint therapies used in Thoroughbred stables. 2.5% PAAG is not a cortisone and shouldn’t be expected to diminish acute inflammation like corticosteroids do. In my opinion, it appears to have the greatest clinical effect in appropriately diagnosed joints with low-grade performance limiting lameness that are treated early in the horse’s preparation, or if utilised within a preparation given time (approximately 3 weeks) before one would expect to see a marked clinical improvement.

“We treated Sound (front fetlocks) in December 2019 which correlates with his turn around in form in February and March 2020, he was again treated in June 2020 (front fetlocks) and July 2020 (left front tendon sheath) after a flare of synovitis. Within 3 weeks both fetlocks and tendon sheath were tight and his action terrific. He went on to run 2nd in the Lexus and win the G2 Zipping Classic (5+ months after injection). As an 8yo stallion Sound tends to hold condition and to reach peak fitness he underwent a tough spring training campaign. On his non gallop days he would complete 4000m of cantering daily, this is a lot of miles on his joints and I do not believe we could have kept him sound without the use of Arthramid. Not only did he perform well but he maintained soundness and his action improved throughout the preparation.”

“This innovative product represents the forefront of cutting-edge medicine, combining advanced technology and research to deliver unparalleled results. I have had several lameness cases that were not responsive to other therapies that look like miracles. The owner of every horse I have treated with Arthramid is so grateful for the improved performance it has given their athletes. It has been particularly beneficial for use in patients with PPIID or ID as a safer solution. I cannot speak highly enough of Arthramid!”